Phenotype and Metabolic Disorders in  Polycystic Ovary Syndrome

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left"> Phenotypical groups:</td><td align="center">A</td><td align="center">B</td><td align="center">C</td><td align="center">D</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">Menstrual disorders (Oligo)</td><td align="center">+</td><td align="center">+</td><td align="center"></td><td align="center">+</td></tr><tr><td align="left">Clinical and/or biochemical hyperandrogenism (HA)</td><td align="center">+</td><td align="center">+</td><td align="center">+</td><td align="center"></td></tr><tr><td align="left">Polycystic ovaries (PCO)</td><td align="center">+</td><td align="center"></td><td align="center">+</td><td align="center">+</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

International Scholarly Research Notices

tab1

Table 1

Table 1: Phenotype and Metabolic Disorders in  Polycystic Ovary Syndrome 